Connection

Shaun Olsen to Models, Molecular

This is a "connection" page, showing publications Shaun Olsen has written about Models, Molecular.
Connection Strength

1.860
  1. Domain alternation and active site remodeling are conserved structural features of ubiquitin E1. J Biol Chem. 2017 07 21; 292(29):12089-12099.
    View in: PubMed
    Score: 0.498
  2. Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation. J Biol Chem. 2007 Dec 21; 282(51):37191-204.
    View in: PubMed
    Score: 0.255
  3. Crystal structures of an E1-E2-ubiquitin thioester mimetic reveal molecular mechanisms of transthioesterification. Nat Commun. 2021 04 22; 12(1):2370.
    View in: PubMed
    Score: 0.163
  4. Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme. Nat Commun. 2018 12 04; 9(1):5145.
    View in: PubMed
    Score: 0.138
  5. Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity. J Biol Chem. 2018 11 23; 293(47):18337-18352.
    View in: PubMed
    Score: 0.137
  6. Structural insights into the mechanism and E2 specificity of the RBR E3 ubiquitin ligase HHARI. Nat Commun. 2017 08 08; 8(1):211.
    View in: PubMed
    Score: 0.126
  7. S.?pombe Uba1-Ubc15 Structure Reveals a Novel Regulatory Mechanism of Ubiquitin E2 Activity. Mol Cell. 2017 Feb 16; 65(4):699-714.e6.
    View in: PubMed
    Score: 0.122
  8. Structure of a ubiquitin E1-E2 complex: insights to E1-E2 thioester transfer. Mol Cell. 2013 Mar 07; 49(5):884-96.
    View in: PubMed
    Score: 0.092
  9. Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature. 2010 Feb 18; 463(7283):906-12.
    View in: PubMed
    Score: 0.075
  10. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev. 2006 Jan 15; 20(2):185-98.
    View in: PubMed
    Score: 0.056
  11. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. J Biol Chem. 2003 Sep 05; 278(36):34226-36.
    View in: PubMed
    Score: 0.047
  12. Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat Commun. 2021 11 25; 12(1):6896.
    View in: PubMed
    Score: 0.042
  13. Designed semisynthetic protein inhibitors of Ub/Ubl E1 activating enzymes. J Am Chem Soc. 2010 Feb 17; 132(6):1748-9.
    View in: PubMed
    Score: 0.019
  14. Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix. Mol Cell Biol. 2009 Sep; 29(17):4663-78.
    View in: PubMed
    Score: 0.018
  15. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol. 2007 May; 27(9):3417-28.
    View in: PubMed
    Score: 0.015
  16. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007 Feb; 117(2):457-63.
    View in: PubMed
    Score: 0.015
  17. A protein canyon in the FGF-FGF receptor dimer selects from an ? la carte menu of heparan sulfate motifs. Curr Opin Struct Biol. 2005 Oct; 15(5):506-16.
    View in: PubMed
    Score: 0.014
  18. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 2005 Apr; 16(2):107-37.
    View in: PubMed
    Score: 0.013
  19. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Mol Cell Biol. 2005 Jan; 25(2):671-84.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.